| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052778 | The Journal of Urology | 2005 | 4 Pages |
Abstract
Ultrasensitive PSA nadir accurately predicts the risk of early biochemical relapse following RP. Men who achieve a nadir of less than 0.01 ng/ml have a low likelihood of early relapse. Higher nadir points may identify candidates for early adjuvant or salvage therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
SAMSON SHEN, HERBERT LEPOR, ROBERT YAFFEE, SAMIR S. TANEJA,